OLIG2 (oligodendrocyte transcription factor 2) is a key basic helix-loop-helix (bHLH) transcription factor that plays a crucial role in the development and maintenance of the central nervous system (CNS). OLIG2 is primarily expressed in neural progenitor cells and is essential for the formation and differentiation of oligodendrocytes (myelin-forming cells of the CNS) as well as motor neurons. Dysregulation of OLIG2 has been implicated in a variety of neurological diseases, including gliomas, and it is often used as a marker for tumorigenic neural stem cells. Due to its involvement in cell fate determination and proliferation, OLIG2 is a key target for research in neurodevelopmental biology, regenerative medicine, and oncology.
Human OLIG2-mCherry adenoviral particles are a powerful molecular tool designed to deliver and express the OLIG2 gene fused to the fluorescent reporter gene mCherry to target cells. These recombinant adenoviral vectors enable efficient transduction in a variety of cell types, including primary neurons, glial cells, and stem cells, promoting stable expression of OLIG2. The mCherry tag enables real-time visualization of OLIG2-expressing cells under fluorescence microscopy, allowing researchers to track cell localization, migration, and differentiation dynamics. This adenoviral system ensures rapid, high-level transgene expression, making it ideal for in vitro and in vivo studies. Applications include studying the role of OLIG2 in neural development, modeling neurological diseases, and screening for potential therapeutics.
The basal ganglia are known for processing information required for multiple aspects of movement and are part of a network that regulates reward and cognition. The major output nucleus of the basal ganglia is the striatum, and its function depends on neuronal compartments, including the striatum and matrix, which are selectively affected in disease. Striatal projection neurons are GABAergic medium spiny neurons (MSNs), which all share basic molecular characteristics but are divided into subtypes based on the selective expression of receptors, neuropeptides, and other gene families. The researchers performed RNA and ATAC sequencing of postnatal day 3 mouse striatal and matrix cells. Focusing on the striatal compartment, they validated the localization and role of transcription factors and their regulators that were previously not known to be involved in striatal development, including Irx1, Foxf2, Olig2, and Stat1/2. In addition, enhancer function was validated for a striatum-specific open chromatin region located 15Kb downstream of the Olig2 gene. These data and databases provide new tools to dissect and manipulate the networks regulating MSN compartmentalization and differentiation, thereby enabling new approaches to establish MSN subtypes from human iPSCs for disease modeling and drug discovery.
Here, researchers determined whether expression of OLIG2 in mouse primary MSNs promotes striatal MSN maturation (Figure 1a). 96 h after transduction with ADV-OLIG2 mCherry, there was no increase in the number of DARPP-32 immunolabeled DIV9 WT primary striatal neurons. ADV-GFP transduced and non-transduced cells were used as controls. These studies showed that expression of OLIG2 from transduced adenovirus did not increase the number of DARPP-32 immunopositive cells (Figure 1b, c); however, it increased mRNA for striatal markers Oprm1, Foxp2, and Rasgrp1 (Figure 1d), but not the stromal marker Calb1.
Figure 1. Olig2 is expressed in MSNs in vitro and its overexpression promotes their maturation towards a striosome phenotype. (Cirnaru M D, et al. 2020)
Customer Reviews
Work well
Accelerated our OLIG2 functional studies significantly. Will repurchase for future work!"
Write a Review